Evidence map›Paper›PMID 9159164›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.

F Rininsland, T R Johnson, C L Chernicky, E Schulze, P Burfeind, J Ilan

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

F RininslandDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
T R Johnson
C L Chernicky
E Schulze
P Burfeind
J Ilan
Case Western Reserve University · US

Funding

CURE AND PREVENTION OF RAT GLIOMA AND HEPATOCARCINOMAR01CA059926 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ILAN, JOSEPH · 1994 to 1996
–
PLACENTAL INTERLEUKIN-2 IN NORMAL &DIABETIC PREGNANCIESR01HD028451 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI ILAN, JUDITH · 1993 to 1995
–
NCI NIH HHS CA 59926NICHD NIH HHS HD-28451
6 · The paper itself

Abstract

Homopurine (AG) and homopyrimidine (CT) oligodeoxyribonucleotides predicted to form triple-helical (triplex) structures have been shown to specifically suppress gene expression when supplied to cultured cells. Here we present evidence that homopurine RNA (effector) sequences designed to form a triplex with a homopurine. homopyrimidine sequence 3' to the termination codon of the insulin-like growth factor type I receptor (IGF-IR) structural gene can efficiently suppress IGF-IR gene transcription. Transfection vectors were constructed to drive transcription of either AG or CT variant triplex-forming strands. To increase the probability of obtaining stable transfectants with adequate expression of effector sequences, these were designed to be transcribed together with cDNA sequences conferring neomycin resistance as a fusion transcript. Rat C6 glioblastoma cells transfected with the AG variant showed dramatic reduction of IGF-IR transcripts compared with untransfected cells. The AG transfectants also exhibited marked down-regulation of the IGF-I, and an enhanced accumulation of serine protease inhibitor nexin-I mRNA. Similar changes in gene expression were observed following transfection of C6 cells with constructs transcribing antisense RNA to IGF-IR transcripts, but were not observed in C6 cells transfected with either the CT triplex variant or with vector lacking triplex-forming sequences. Moreover, C6 cells transfected with AG triplex variant displayed a dramatic inhibition of tumor growth when injected into nude mice. The results suggest that a triple-helix strategy can be used to inhibit transcription elongation of the IGF-IR gene, and emphasize the efficacy of triplex-mediated gene inhibition in an animal model.

Indexed as

Amyloid beta-Protein PrecursorAnimalsBase SequenceCarrier ProteinsCell DivisionDown-RegulationGlioblastomaInsulin-Like Growth Factor IMiceMice, NudeNucleic Acid ConformationOligodeoxyribonucleotidesProbabilityProtease NexinsRatsReceptor, IGF Type 1Amyloid beta-Protein PrecursorCarrier ProteinsInsulin-Like Growth Factor IOligodeoxyribonucleotidesProtease NexinsReceptor, IGF Type 1Receptors, Cell SurfaceRecombinant ProteinsRNA, AntisenseRNA, MessengerSerine Proteinase Inhibitors

Identifiers

PMID9159164
PMCPMC20870
OpenAlexW2000141884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.